Search

everythinglearnresearchcommunity

for

Search:↓

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Lowering testosterone speeds up wound healing in male mice.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Spironolactone harms fish reproduction and is more potent in fish than invertebrates, needing environmental monitoring.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Dutasteride and finasteride affect different cell types differently.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Fluridil promotes hair growth safely and effectively for androgenetic alopecia.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Male pattern baldness is linked to higher levels of a certain receptor in the scalp, which leads to the shrinking of blood vessels and hair loss. Early treatment targeting this receptor could be more effective.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Minoxidil can reduce functions related to androgen receptors.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Scientists restored fertility in male mice lacking a key fertility gene by using a modified gene.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

Platelet factor 4 slows down hair growth and could make hair loss treatments more effective if removed.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

TGF-β1 from dermal papilla cells suppresses hair growth, and targeting it may help treat androgenetic alopecia.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.